ERBB2 and breast carcinoma: Firstly, the serum levels of DKK-1 in patients with breast cancer was significantly higher than that in healthy individuals, and high serum levels of DKK-1 was found to significantly correlate with TNM stage, tumor grade, lymph node metastasis, and expression of HER2.